Browsing by Author "Fadieienko, Galyna"
Now showing 1 - 11 of 11
- Results Per Page
- Sort Options
Item Interleukin 15 in nonalcoholic fatty liver disease and obesity(2015-04) Kurinna, Olena; Курінна, Олена Григорівна; Fadieienko, Galyna; Фадєєнко, Галина Дмитрівна; Babak, Oleg; Бабак, Олег Якович; Solomentseva, Tatyana; Соломенцева, Тетяна Анатоліївна; Sytnyk, Kseniia; Ситник, Ксенія ОлександрівнаОписаны изменения Il15 у больных с неалкогольной жировой болезнью и ожирениемItem Management of patient with a heart murmur(2012) Babak, Oleg; Fadieienko, Galyna; Zaichenko, Olga; Tveretinov, A.; Shaposhnikova, YuliyaThe aim of this module is to provide the student with an opportunity to keeping patient in cardiology clinic. Student must know causes of heart murmurs. Etiology, pathogenesis. Haemodynamics. Clinical finding, treatment. Surgical treatment the Heart valve disease. Students should be able to execute assessment, diagnosis and management the patient with a heart murmur. To obtain the skills of interpretation of Doppler echocardioscopy. To obtain the skills of interpretation of the results of stress tests. To obtain the skills of interpretation of electrocardiograms.Item Management of patients with chronic abdominal pain(КNMU, 2012) Babak, Oleg; Fadieienko, Galyna; Gaponova, OlgaDifferent conditions which can cause chronic abdominal pain, main investigations differentiating it’s causes, modern strategies of diagnostics and treatment of chronic abdominal pain, psychosocial presentations of chronic abdominal pain are described.Item Management of patients with infiltrative pulmonary darkening(2012) Babak, Oleg; Bilovol, Olexandr; Fadieienko, Galyna; Shkolnik, Vira; Shaposhnikova, Yuliya; Nemtsova, Valeriya; Zhelezniakova, NataliaThe aim of this module is to provide the student with an opportunity to keeping patient in pulmonology clinic. Students should be able to describe and define: what is mean by the term fever of unknown origin, the basic mechanisms of fever of unknown origin. The student should have an understanding of the pathophysiology of these diseases and be able to develop a comprehensive differential diagnosis. The student will understand the appropriate diagnostic testing, the assessment, diagnosis and management the patient with fever of unknown origin.Item Management of patients with pleural effusion(2012) Babak, Oleg; Fadieienko, Galyna; Nemtsova, Valeriya; Shaposhnikova, Yuliya; Shkolnik, Vira; Zhelezniakova, NataliaThe students should be able to describe clinical presentation, provide the diagnose, differentials and treatment of pleurisy The aim of this topic is to provide the student with an opportunity to: provide a basic overview of the pathophysiology, history, and the main causes of pleurisy; provide a diagnostic steps for the patients with suspected pleural effusion; provide a classification of transudates and exudates, asses the results of labs and images in different variants of pleural effusion, discuss the procedure of diagnostic and therapeutic thoracentesis(goals, indications, contraindication, techniqueof the procedure),discuss the treatment (medical and surgical care) of different types of pleurisy.Item Management of the patients with hepatic encephalopathy(2012) Babak, Oleg; Fadieienko, Galyna; Zhelezniakova, Natalia; Nemtsova, Valeriya; Shaposhnikova, Yuliya; Shkolnik, ViraManagement of the patients with hepatic encephalopathy: classification, etiopathogenesis, clinical features, diagnostic, treatment.Item Management of the patients with hypertension(KNMU, 2012) Babak, Oleg; Fadieienko, Galyna; Shaposhnikova, Yuliya; Shkolnik, Vira; Nemtsova, Valeriya; Zhelezniakova, Natalia; Zaichenko, OlgaMain links of pathogenesis, clinical features, diagnostic and treatment of arterial hypertension are described.Item Module 3. Current practice of internal medicine. Contents module№ 1. Theme 9. Management of the patients with stable angina(2012) Babak, Oleg; Fadieienko, Galyna; Shaposhnikova, Yuliya; Shkolnik, Vira; Nemtsova, Valeriya; Zhelezniakova, Natalia; Zaichenko, OlgaManagement of the patients with stable angina: introduction, Canadian Cardiovascular Society Angina Classes, main causes of decreased myocardial oxygen supply or increased myocardial oxygen demands, diagnosis, assessment, general measures and treatment.Item Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy(2014-03) Rockey, Don; Vierling, John; Mantry, Parvez; Ghabril, Marwan; Brown, Robert; Alexeeva, Olga; Zupanets, Igor; Grinevich, Vladimir; Baranovsky, Andrey; Dudar, Larysa; Fadieienko, Galyna; Kharchenko, Nataliya; Klaryts’ka, Iryna; Morozov, Vyacheslav; Grewal, Priya; McCashland, Timothy; Reddy, Gautham; Reddy, Rajender; Syplyviy, Vasyl; Bass, Nathan; Dickinson, Klara; Norris, Catherine; Coakley, Dion; Mokhtarani, Masoud; Scharschmidt, BruceGlycerol phenylbutyrate (GPB) lowers ammonia by providing an alternate pathway to urea for waste nitrogen excretion in the form of phenylacetyl glutamine, which is excreted in urine. This randomized, double-blind, placebo-controlled phase II trial enrolled 178 patients with cirrhosis, including 59 already taking rifaximin, who had experienced two or more hepatic encephalopathy (HE) events in the previous 6 months. The primary endpoint was the proportion of patients with HE events. Other endpoints included the time to first event, total number of events, HE hospitalizations, symptomatic days, and safety. GPB, at 6 mL orally twice-daily, significantly reduced the proportion of patients who experienced an HE event (21% versus 36%; P=0.02), time to first event (hazard ratio [HR]=0.56; P<0.05), as well as total events (35 versus 57; P=0.04), and was associated with fewer HE hospitalizations (13 versus 25; P=0.06). Among patients not on rifaximin at enrollment, GPB reduced the proportion of patients with an HE event (10% versus 32%; P<0.01), time to first event (HR=0.29; P<0.01), and total events (7 versus 31; P<0.01). Plasma ammonia was significantly lower in patients on GPB and correlated with HE events when measured either at baseline or during the study. A similar proportion of patients in the GPB (79%) and placebo groups (76%) experienced adverse events.Item Role of interleukin 15 in liver fat accumulation in patients with concomitant obesity(2015) Fadieienko, Galyna; Babak, Oleg; Kolesnikova, Olena; Solomentseva, Tatyana; Kurinna, Olena; Sytnyk, KseniiaItem Selenium deficiency and pain in chronic pancreatitis(2012) Fadieienko, Galyna; Prosolenko, Kostyantyn; Shalimova, AnnaSodium selenite is an effective drug in treatment of selenium deficiency and could be used in initial complex therapy for pain relief in chronic pancreatitis.